Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
According to APO Research, The global Glucagon Like Peptide-1 (GLP-1) Agonists market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Glucagon Like Peptide-1 (GLP-1) Agonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Glucagon Like Peptide-1 (GLP-1) Agonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Glucagon Like Peptide-1 (GLP-1) Agonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists include Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb and Amylin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucagon Like Peptide-1 (GLP-1) Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon Like Peptide-1 (GLP-1) Agonists.
The Glucagon Like Peptide-1 (GLP-1) Agonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucagon Like Peptide-1 (GLP-1) Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon Like Peptide-1 (GLP-1) Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon Like Peptide-1 (GLP-1) Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon Like Peptide-1 (GLP-1) Agonists.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glucagon Like Peptide-1 (GLP-1) Agonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Glucagon Like Peptide-1 (GLP-1) Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
According to APO Research, The global Glucagon Like Peptide-1 (GLP-1) Agonists market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Glucagon Like Peptide-1 (GLP-1) Agonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Glucagon Like Peptide-1 (GLP-1) Agonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Glucagon Like Peptide-1 (GLP-1) Agonists is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists include Novo Nordisk, AstraZeneca, Eli Lily, GSK, Sanofi, Bristol-Myers Squibb and Amylin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Glucagon Like Peptide-1 (GLP-1) Agonists, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon Like Peptide-1 (GLP-1) Agonists.
The Glucagon Like Peptide-1 (GLP-1) Agonists market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucagon Like Peptide-1 (GLP-1) Agonists market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Novo Nordisk
- AstraZeneca
- Eli Lily
- GSK
- Sanofi
- Bristol-Myers Squibb
- Amylin
- Exenatied
- Liraglutide
- Lixisenatide
- Albiglutide
- Dulaglutide
- Hospital
- Pharmacy
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon Like Peptide-1 (GLP-1) Agonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucagon Like Peptide-1 (GLP-1) Agonists and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon Like Peptide-1 (GLP-1) Agonists.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Glucagon Like Peptide-1 (GLP-1) Agonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Glucagon Like Peptide-1 (GLP-1) Agonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Estimates and Forecasts (2019-2030)
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Type
1.3.1 Exenatied
1.3.2 Liraglutide
1.3.3 Lixisenatide
1.3.4 Albiglutide
1.3.5 Dulaglutide
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Type (2019-2030)
1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size Review by Type (2019-2024)
1.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
1.5.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Drivers
2.3 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Opportunities and Challenges
2.4 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2019-2024)
3.2 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Sales (2019-2024)
3.3 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Price (2019-2024)
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Key Company Manufacturing Sites & Headquarters
3.6 Global Glucagon Like Peptide-1 (GLP-1) Agonists Company, Product Type & Application
3.7 Global Glucagon Like Peptide-1 (GLP-1) Agonists Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market CR5 and HHI
3.8.2 Global Top 5 and 10 Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share by Revenue in 2023
3.8.3 2023 Glucagon Like Peptide-1 (GLP-1) Agonists Tier 1, Tier 2, and Tier
4 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS REGIONAL STATUS AND OUTLOOK
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size by Region
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2019-2024)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Region (2019-2024)
4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Region
4.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2025-2030)
4.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Region (2025-2030)
4.3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS BY APPLICATION
5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Application
5.1.1 Hospital
5.1.2 Pharmacy
5.1.3 Other
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Application (2019-2030)
5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size Review by Application (2019-2024)
5.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
5.3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Novo Nordisk
6.1.1 Novo Nordisk Comapny Information
6.1.2 Novo Nordisk Business Overview
6.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.1.5 Novo Nordisk Recent Developments
6.2 AstraZeneca
6.2.1 AstraZeneca Comapny Information
6.2.2 AstraZeneca Business Overview
6.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.2.5 AstraZeneca Recent Developments
6.3 Eli Lily
6.3.1 Eli Lily Comapny Information
6.3.2 Eli Lily Business Overview
6.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.3.5 Eli Lily Recent Developments
6.4 GSK
6.4.1 GSK Comapny Information
6.4.2 GSK Business Overview
6.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.4.5 GSK Recent Developments
6.5 Sanofi
6.5.1 Sanofi Comapny Information
6.5.2 Sanofi Business Overview
6.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.5.5 Sanofi Recent Developments
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Comapny Information
6.6.2 Bristol-Myers Squibb Business Overview
6.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments
6.7 Amylin
6.7.1 Amylin Comapny Information
6.7.2 Amylin Business Overview
6.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.7.5 Amylin Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
7.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
7.1.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
7.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
7.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
7.2.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
8.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
8.1.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
8.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
8.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
8.2.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
9.1.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
9.1.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
9.2.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
10.1.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
10.1.3 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
10.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
10.2.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
10.2.3 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
11.1.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
11.1.3 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
11.2.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Glucagon Like Peptide-1 (GLP-1) Agonists Value Chain Analysis
12.1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Glucagon Like Peptide-1 (GLP-1) Agonists Production Mode & Process
12.2 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors
12.2.3 Glucagon Like Peptide-1 (GLP-1) Agonists Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Estimates and Forecasts (2019-2030)
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Type
1.3.1 Exenatied
1.3.2 Liraglutide
1.3.3 Lixisenatide
1.3.4 Albiglutide
1.3.5 Dulaglutide
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Type (2019-2030)
1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size Review by Type (2019-2024)
1.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
1.5.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Drivers
2.3 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Opportunities and Challenges
2.4 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2019-2024)
3.2 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Sales (2019-2024)
3.3 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Price (2019-2024)
3.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Glucagon Like Peptide-1 (GLP-1) Agonists Key Company Manufacturing Sites & Headquarters
3.6 Global Glucagon Like Peptide-1 (GLP-1) Agonists Company, Product Type & Application
3.7 Global Glucagon Like Peptide-1 (GLP-1) Agonists Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market CR5 and HHI
3.8.2 Global Top 5 and 10 Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share by Revenue in 2023
3.8.3 2023 Glucagon Like Peptide-1 (GLP-1) Agonists Tier 1, Tier 2, and Tier
4 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS REGIONAL STATUS AND OUTLOOK
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size by Region
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2019-2024)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Region (2019-2024)
4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Region
4.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2025-2030)
4.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Region (2025-2030)
4.3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS BY APPLICATION
5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market by Application
5.1.1 Hospital
5.1.2 Pharmacy
5.1.3 Other
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Application (2019-2030)
5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size Review by Application (2019-2024)
5.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
5.3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Novo Nordisk
6.1.1 Novo Nordisk Comapny Information
6.1.2 Novo Nordisk Business Overview
6.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.1.5 Novo Nordisk Recent Developments
6.2 AstraZeneca
6.2.1 AstraZeneca Comapny Information
6.2.2 AstraZeneca Business Overview
6.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.2.5 AstraZeneca Recent Developments
6.3 Eli Lily
6.3.1 Eli Lily Comapny Information
6.3.2 Eli Lily Business Overview
6.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.3.5 Eli Lily Recent Developments
6.4 GSK
6.4.1 GSK Comapny Information
6.4.2 GSK Business Overview
6.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.4.5 GSK Recent Developments
6.5 Sanofi
6.5.1 Sanofi Comapny Information
6.5.2 Sanofi Business Overview
6.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.5.5 Sanofi Recent Developments
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Comapny Information
6.6.2 Bristol-Myers Squibb Business Overview
6.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments
6.7 Amylin
6.7.1 Amylin Comapny Information
6.7.2 Amylin Business Overview
6.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.7.5 Amylin Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
7.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
7.1.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
7.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
7.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
7.2.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
8.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
8.1.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
8.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
8.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
8.2.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
9.1.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
9.1.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
9.2.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
10.1.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
10.1.3 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
10.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
10.2.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
10.2.3 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country
11.1.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024)
11.1.3 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country
11.2.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Glucagon Like Peptide-1 (GLP-1) Agonists Value Chain Analysis
12.1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Glucagon Like Peptide-1 (GLP-1) Agonists Production Mode & Process
12.2 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors
12.2.3 Glucagon Like Peptide-1 (GLP-1) Agonists Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Exenatied
Table 2. Major Company of Liraglutide
Table 3. Major Company of Lixisenatide
Table 4. Major Company of Albiglutide
Table 5. Major Company of Dulaglutide
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type (2019-2024)
Table 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type (2019-2024)
Table 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2025-2030) & (K Units)
Table 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type (2025-2030)
Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2025-2030) & (US$ Million)
Table 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type (2025-2030)
Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2025-2030) & (USD/Unit)
Table 17. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 18. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 19. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 20. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 21. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 22. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 23. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 24. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 25. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 26. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 27. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
Table 28. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Drivers
Table 29. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Opportunities and Challenges
Table 30. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Restraints
Table 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue by Company (US$ Million) & (2019-2024)
Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2019-2024)
Table 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2019-2024) & (K Units)
Table 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Company (2019-2024)
Table 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Price by Company (2019-2024) & (USD/Unit)
Table 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Industry Company Ranking, 2022 VS 2023 VS 2024
Table 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Key Company Manufacturing Sites & Headquarters
Table 38. Global Glucagon Like Peptide-1 (GLP-1) Agonists Company, Product Type & Application
Table 39. Global Glucagon Like Peptide-1 (GLP-1) Agonists Company Commercialization Time
Table 40. Global Company Market Concentration Ratio (CR5 and HHI)
Table 41. Global Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 42. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2019-2024) & (K Units)
Table 44. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Region (2019-2024)
Table 45. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2019-2024) & (US$ Million)
Table 46. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Region (2019-2024)
Table 47. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2025-2030) & (K Units)
Table 49. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Region (2025-2030)
Table 50. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2025-2030) & (US$ Million)
Table 51. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Region (2025-2030)
Table 52. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2025-2030)
Table 53. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 54. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 55. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application (2019-2024)
Table 56. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 57. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application (2019-2024)
Table 58. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2025-2030) & (K Units)
Table 60. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application (2025-2030)
Table 61. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2025-2030) & (US$ Million)
Table 62. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application (2025-2030)
Table 63. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2025-2030) & (USD/Unit)
Table 64. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 65. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 66. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 67. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 68. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 69. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 70. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 71. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 72. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 73. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 74. Novo Nordisk Company Information
Table 75. Novo Nordisk Business Overview
Table 76. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 78. Novo Nordisk Recent Development
Table 79. AstraZeneca Company Information
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 83. AstraZeneca Recent Development
Table 84. Eli Lily Company Information
Table 85. Eli Lily Business Overview
Table 86. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 88. Eli Lily Recent Development
Table 89. GSK Company Information
Table 90. GSK Business Overview
Table 91. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 93. GSK Recent Development
Table 94. Sanofi Company Information
Table 95. Sanofi Business Overview
Table 96. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 98. Sanofi Recent Development
Table 99. Bristol-Myers Squibb Company Information
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Amylin Company Information
Table 105. Amylin Business Overview
Table 106. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 108. Amylin Recent Development
Table 109. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 110. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 111. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 112. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 113. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 114. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 115. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 116. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 117. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 118. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 119. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 120. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 121. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 122. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 123. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 124. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 125. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 126. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 127. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 128. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 129. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 130. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 131. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 132. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 133. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 134. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 135. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 136. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 137. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 138. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 139. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 140. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 141. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 142. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 143. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 144. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 145. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 146. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 147. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 148. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 149. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 150. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 151. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 152. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 153. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 154. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 155. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 156. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 157. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 158. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 159. Key Raw Materials
Table 160. Raw Materials Key Suppliers
Table 161. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table 162. Glucagon Like Peptide-1 (GLP-1) Agonists Customers List
Table 163. Research Programs/Design for This Report
Table 164. Authors List of This Report
Table 165. Secondary Sources
Table 166. Primary Sources
Table 1. Major Company of Exenatied
Table 2. Major Company of Liraglutide
Table 3. Major Company of Lixisenatide
Table 4. Major Company of Albiglutide
Table 5. Major Company of Dulaglutide
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type (2019-2024)
Table 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type (2019-2024)
Table 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2025-2030) & (K Units)
Table 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type (2025-2030)
Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2025-2030) & (US$ Million)
Table 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type (2025-2030)
Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2025-2030) & (USD/Unit)
Table 17. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 18. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 19. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 20. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 21. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 22. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 23. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 24. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 25. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (K Units)
Table 26. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2019-2024) & (US$ Million)
Table 27. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
Table 28. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Drivers
Table 29. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Opportunities and Challenges
Table 30. Glucagon Like Peptide-1 (GLP-1) Agonists Industry Restraints
Table 31. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Revenue by Company (US$ Million) & (2019-2024)
Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Company (2019-2024)
Table 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2019-2024) & (K Units)
Table 34. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Company (2019-2024)
Table 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Price by Company (2019-2024) & (USD/Unit)
Table 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Industry Company Ranking, 2022 VS 2023 VS 2024
Table 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Key Company Manufacturing Sites & Headquarters
Table 38. Global Glucagon Like Peptide-1 (GLP-1) Agonists Company, Product Type & Application
Table 39. Global Glucagon Like Peptide-1 (GLP-1) Agonists Company Commercialization Time
Table 40. Global Company Market Concentration Ratio (CR5 and HHI)
Table 41. Global Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 42. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2019-2024) & (K Units)
Table 44. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Region (2019-2024)
Table 45. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2019-2024) & (US$ Million)
Table 46. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Region (2019-2024)
Table 47. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2025-2030) & (K Units)
Table 49. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Region (2025-2030)
Table 50. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2025-2030) & (US$ Million)
Table 51. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Region (2025-2030)
Table 52. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2025-2030)
Table 53. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 54. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 55. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application (2019-2024)
Table 56. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 57. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application (2019-2024)
Table 58. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2025-2030) & (K Units)
Table 60. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application (2025-2030)
Table 61. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2025-2030) & (US$ Million)
Table 62. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application (2025-2030)
Table 63. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2025-2030) & (USD/Unit)
Table 64. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 65. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 66. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 67. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 68. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 69. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 70. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 71. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 72. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (K Units)
Table 73. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2019-2024) & (US$ Million)
Table 74. Novo Nordisk Company Information
Table 75. Novo Nordisk Business Overview
Table 76. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 78. Novo Nordisk Recent Development
Table 79. AstraZeneca Company Information
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 83. AstraZeneca Recent Development
Table 84. Eli Lily Company Information
Table 85. Eli Lily Business Overview
Table 86. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 88. Eli Lily Recent Development
Table 89. GSK Company Information
Table 90. GSK Business Overview
Table 91. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 93. GSK Recent Development
Table 94. Sanofi Company Information
Table 95. Sanofi Business Overview
Table 96. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 98. Sanofi Recent Development
Table 99. Bristol-Myers Squibb Company Information
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 103. Bristol-Myers Squibb Recent Development
Table 104. Amylin Company Information
Table 105. Amylin Business Overview
Table 106. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
Table 108. Amylin Recent Development
Table 109. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 110. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 111. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 112. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 113. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 114. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 115. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 116. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 117. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 118. North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 119. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 120. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 121. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 122. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 123. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 124. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 125. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 126. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 127. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 128. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 129. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 130. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 131. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 132. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 133. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 134. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 135. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 136. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 137. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 138. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 139. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 140. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 141. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 142. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 143. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 144. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 145. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 146. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 147. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 148. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 149. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (K Units): 2019 VS 2023 VS 2030
Table 150. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2019-2024) & (K Units)
Table 151. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2019-2024)
Table 152. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Forecast by Country (2025-2030) & (K Units)
Table 153. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share Forecast by Country (2025-2030)
Table 154. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 155. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country (2019-2024) & (US$ Million)
Table 156. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Country (2019-2024)
Table 157. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 158. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Forecast by Country (2025-2030)
Table 159. Key Raw Materials
Table 160. Raw Materials Key Suppliers
Table 161. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table 162. Glucagon Like Peptide-1 (GLP-1) Agonists Customers List
Table 163. Research Programs/Design for This Report
Table 164. Authors List of This Report
Table 165. Secondary Sources
Table 166. Primary Sources
LIST OF FIGURES
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2019-2030) & (US$ Million)
Figure 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (2019-2030) & (K Units)
Figure 5. Product Picture of Exenatied
Figure 6. Global Exenatied Sales YoY Growth (2019-2030) & (K Units)
Figure 7. Product Picture of Liraglutide
Figure 8. Global Liraglutide Sales YoY Growth (2019-2030) & (K Units)
Figure 9. Product Picture of Lixisenatide
Figure 10. Global Lixisenatide Sales YoY Growth (2019-2030) & (K Units)
Figure 11. Product Picture of Albiglutide
Figure 12. Global Albiglutide Sales YoY Growth (2019-2030) & (K Units)
Figure 13. Product Picture of Dulaglutide
Figure 14. Global Dulaglutide Sales YoY Growth (2019-2030) & (K Units)
Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type 2023 VS 2030
Figure 17. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 18. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 19. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 20. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 21. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 22. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 23. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 24. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 25. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 26. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 27. Global Top 5 and 10 Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share by Revenue in 2023
Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 29. Product Picture of Hospital
Figure 30. Global Hospital Sales YoY Growth (2019-2030) & (K Units)
Figure 31. Product Picture of Pharmacy
Figure 32. Global Pharmacy Sales YoY Growth (2019-2030) & (K Units)
Figure 33. Product Picture of Other
Figure 34. Global Other Sales YoY Growth (2019-2030) & (K Units)
Figure 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2019-2030) & (US$ Million)
Figure 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (2019-2030) & (K Units)
Figure 5. Product Picture of Exenatied
Figure 6. Global Exenatied Sales YoY Growth (2019-2030) & (K Units)
Figure 7. Product Picture of Liraglutide
Figure 8. Global Liraglutide Sales YoY Growth (2019-2030) & (K Units)
Figure 9. Product Picture of Lixisenatide
Figure 10. Global Lixisenatide Sales YoY Growth (2019-2030) & (K Units)
Figure 11. Product Picture of Albiglutide
Figure 12. Global Albiglutide Sales YoY Growth (2019-2030) & (K Units)
Figure 13. Product Picture of Dulaglutide
Figure 14. Global Dulaglutide Sales YoY Growth (2019-2030) & (K Units)
Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type 2023 VS 2030
Figure 17. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 18. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 19. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 20. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 21. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 22. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 23. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 24. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 25. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2023
Figure 26. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2023
Figure 27. Global Top 5 and 10 Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share by Revenue in 2023
Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 29. Product Picture of Hospital
Figure 30. Global Hospital Sales YoY Growth (2019-2030) & (K Units)
Figure 31. Product Picture of Pharmacy
Figure 32. Global Pharmacy Sales YoY Growth (2019-2030) & (K Units)
Figure 33. Product Picture of Other
Figure 34. Global Other Sales YoY Growth (2019-2030) & (K Units)
Figure 35. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market
